A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
In cases of Alzheimer's presenile and senile dementia, Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT), respectively, we have observed, in addition to the gray matter degeneration, a lesion that has the character of an incomplete infarction confined to the white matter. It is encountered in 60% of both groups, with mild changes in two thirds and moderate or severe changes in one third. It involves the deep white matter symmetrically, tapering off toward the cortex. It is characterized by partial loss of myelin, axons, and oligodendroglial cells; mild reactive astrocytic gliosis; and sparsely distributed macrophages as well as stenosis resulting from hyaline fibrosis of arterioles and smaller vessels. No complete or cavitating infarctions and no hypertensive vascular changes were observed. The white matter changes are thought to be due to hypoperfusion of the concerned white matter territories since, in addition to the white matter hyaline vascular stenosis, these cases show signs of cardiovascular disease, usually with hypotension. The white matter disorder also occurs independent of the gray matter process of AD and SDAT and may be seen as the sole brain lesion in non‐AD subjects. Its occurrence is thus neither regularly related to the severity nor to the regional appearance and accentuation of the cortical Alzheimer process and is thus not likely to be just the result of a wallerian degeneration. Histologically it is similar in several respects to Binswanger's disease, although with some distinct differences. It is thus related to the cerebrovascular group of disorders in addition to AD and SDAT. In view of its frequency and severity, this white matter lesion is important to define, to diagnose, and ultimately to prevent or cure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“White matter degeneration and microbleeds most likely reflect direct tissue damage,71,78–80”
In the citing paper
“white matter degeneration is related to Alzheimer disease pathology78”
In the citing paper
“white matter degeneration is related to Alzheimer disease pathology78 and microbleeds to CAA.”
In the citing paper
“In Alzheimer’s disease, white matter degeneration is a frequent structural brain change apart from grey matter atrophy (Brun and Englund, 1986).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Brun and Englund, 1986
In the citing paper
“Such white matter alterations cannot be fully accounted for as degenerative processes secondary to grey matter damage (Brun and Englund, 1986; Englund, 1998; Agosta et al., 2011), but may stem from vascular amyloid deposition and microvascular damage (Weller et al., 2009).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Brun and Englund, 1986
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Lipcsey, A. (1980) · PubMed · Cited by 1,083
Walton, J. N. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90157-x · Cited by 964
Distribution and fatty acid composition of phosphoglycerides in normal human brain
Svennerholm, L. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42702-6 · Cited by 639
Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading
BRUN, A., & ENGLUND, E. (1981) · Histopathology · doi:10.1111/j.1365-2559.1981.tb01818.x · Cited by 561
Self-citationDistribution of cerebral degeneration in Alzheimer's disease: A clinico-pathological study
Brun, A., & Gustafson, L. (1976) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00367450 · Cited by 397
Self-citationClinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease)
Caplan, L. R., & Schoene, W. C. (1978) · Neurology · doi:10.1212/wnl.28.12.1206 · Cited by 282
Computed Tomography in the Elderly 2. Senile Dementia: Diagnosis and Functional Impairment
Jacoby, R. J., & Levy, R. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.136.3.256 · Cited by 205
Goto, K., Ishii, N., & Fukasawa, H. (1981) · Radiology · doi:10.1148/radiology.141.3.7302224 · Cited by 181
OLSZEWSKI, J. (1962) · PubMed · Cited by 161
Subcortical arteriosclerotic encephalopathy: a clinical and radiological investigation.
Loizou, L. A., Kendall, B. E., & Marshall, J. (1981) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.44.4.294 · Cited by 139
Research works printed but not linked: 6
- Auff E, 1980, Contribution to the problem of presenile glial dystrophy, Neuropathology, 1, 113
- Binswanger O, 1984, Die Abgrenzung der allgemeinen progressiven Paralyse, Berl Klin Wochenschr, 31, 1103
- 1981, Editorial 1981.: Binswanger's encephalopathy, Lancet, 1, 923
- George AE, 1981, Parenchymal CT correlates of senile dementia (Alzheimer's disease): loss of grey‐white matter discriminability, AJNR, 2, 205
- Gustafson L, 1984, Proceedings of the VII World Congress of Psychiatry 1983
- Sternby NH, 1968, Atherosclerosis in a defined population, Acta Pathol Microbiol Scand Suppl, 194
Cited by
Items 101–200 of 1,000
Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia
Iadecola, C., & Gorelick, P. B. (2003) · Stroke · doi:10.1161/01.str.0000054050.51530.76 · Cited by 207
Tomimoto, H., Akiguchi, I., Suenaga, T., Nishimura, M., Wakita, H., Nakamura, S., & Kimura, J. (1996) · Stroke · doi:10.1161/01.str.27.11.2069 · Cited by 204
Leukoencephalopathy in elderly depressed patients referred for ECT
Coffey, C. E., Figiel, G. S., Djang, W. T., Cress, M., Saunders, W. B., & Weiner, R. D. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90270-3 · Cited by 204
Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases
Jernigan, T. L., Salmon, D. P., Butters, N., & Hesselink, J. R. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90211-4 · Cited by 198
White-Matter Hyperintensity and Neuropsychological Functions in Dementia and Healthy Aging
Almkvist, O., Wahlund, L.-O., Andersson-Lundman, G., Basun, H., & Backman, L. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530300062011 · Cited by 195
Cellular Senescence in Postmitotic Cells: Beyond Growth Arrest
Sapieha, P., & Mallette, F. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.03.003 · Cited by 193
Pathologic Correlates of Increased Signals of the Centrum Ovale on Magnetic Resonance Imaging
Munoz, D. G., Hastak, S. M., Harper, B., Lee, D., & Hachinski, V. C. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540050044013 · Cited by 193
Ohta, H., Nishikawa, H., Kimura, H., Anayama, H., & Miyamoto, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00037-7 · Cited by 192
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
Weinreb, O., Mandel, S., Youdim, M. B. H., & Amit, T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.017 · Cited by 190
Clinical diagnosis of Binswanger's disease.
Bennett, D. A., Wilson, R. S., Gilley, D. W., & Fox, J. H. (1990) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.11.961 · Cited by 190
Thomas, T., Miners, S., & Love, S. (2015) · Brain · doi:10.1093/brain/awv025 · Cited by 190
“As many as 60% of patients were reported to have ischaemic white matter damage (Brun and Englund, 1986a, b; Englund et al., 1988; Brun et al., 1990; Englund and Brun, 1990; Kalaria, 2000), attributed to arteriolosclerotic small vessel disease.”
BackgroundJelescu, I. O., Zurek, M., Winters, K. V., Veraart, J., Rajaratnam, A., Kim, N. S., Babb, J. S., Shepherd, T. M., Novikov, D. S., Kim, S. G., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.004 · Cited by 188
“Demyelination and/or remyelination are important components of several complex pathologies, such as multiple sclerosis (Grossman and McGowan, 1998; Hommes, 1980), as well as Alzheimer's disease (Brun and Englund, 1986), schizophrenia (Davis et al.”
Binswanger's encephalopathy: a review
Miller Fisher, C. (1989) · Journal of Neurology · doi:10.1007/bf00314400 · Cited by 188
Clinical Correlates of White-Matter Changes on Magnetic Resonance Imaging Scans of the Brain
Mirsen, T. R., Lee, D. H., Wong, C. J., Diaz, J. F., Fox, A. J., Hachinski, V. C., & Merskey, H. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530220031015 · Cited by 188
Dyrba, M., Grothe, M., Kirste, T., & Teipel, S. J. (2015) · Human Brain Mapping · doi:10.1002/hbm.22759 · Cited by 187
Blennow, K., Wallin, A., Uhlemann, C., & Gottfries, C. G. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb04675.x · Cited by 187
Focal demyelination in Alzheimer’s disease and transgenic mouse models
Mitew, S., Kirkcaldie, M. T. K., Halliday, G. M., Shepherd, C. E., Vickers, J. C., & Dickson, T. C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0657-2 · Cited by 186
Leuko-Araiosis: An Ancient Term for a New Problem
Hachinski, V. C., Potter, P., & Merskey, H. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037264 · Cited by 186
Medullary arteries in aging and dementia.
Furuta, A., Ishii, N., Nishihara, Y., & Horie, A. (1991) · Stroke · doi:10.1161/01.str.22.4.442 · Cited by 185
White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
Araque Caballero, M. Á., Suárez-Calvet, M., Duering, M., Franzmeier, N., Benzinger, T., Fagan, A. M., Bateman, R. J., Jack, C. R., Levin, J., Dichgans, M., et al. (2018) · Brain · doi:10.1093/brain/awy229 · Cited by 184
Bocti, C., Swartz, R. H., Gao, F.-Q., Sahlas, D. J., Behl, P., & Black, S. E. (2005) · Stroke · doi:10.1161/01.str.0000183615.07936.b6 · Cited by 182
“Each slice was weighted to account for the decreasing concentration of cholinergic fibers as they project up and fan out in the white matter (maximum weight (4) for slice 1; minimal weight (1) for slice 4).”
Hedden, T., Mormino, E. C., Amariglio, R. E., Younger, A. P., Schultz, A. P., Becker, J. A., Buckner, R. L., Johnson, K. A., Sperling, R. A., & Rentz, D. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2462-12.2012 · Cited by 182
Bozzao, A., Floris, R., Baviera, M. E., Apruzzese, A., & Simonetti, G. (2001) · PubMed · Cited by 180
Gray and white matter changes in Alzheimer's disease: a diffusion tensor imaging study
Rose, S. E., Janke PhD, A. L., & Chalk, J. B. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21231 · Cited by 178
Status of Risk Factors for Vascular Dementia
Skoog, I. (1998) · Neuroepidemiology · doi:10.1159/000026147 · Cited by 178
Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease
Hanyu, H., Sakurai, H., Iwamoto, T., Takasaki, M., Shindo, H., & Abe, K. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00043-4 · Cited by 176
Cerebral Microvascular Alterations in Aging, Leukoaraiosis, and Alzheimer's Diseasea
MOODY, D. M., BROWN, W. R., CHALLA, V. R., GHAZI‐BIRRY, H. S., & REBOUSSIN, D. M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48464.x · Cited by 157
Lee, G. J., Lu, P. H., Hua, X., Lee, S., Wu, S., Nguyen, K., Teng, E., Leow, A. D., Jack, C. R., Toga, A. W., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.024 · Cited by 173
Brain White-Matter Changes in the Elderly Prone to Falling
Masdeu, J. C., Wolfson, L., Lantos, G., Tobin, J. N., Grober, E., Whipple, R., & Amerman, P. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520480034016 · Cited by 171
Gold, B. T., Johnson, N. F., Powell, D. K., & Smith, C. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.009 · Cited by 170
“However, ever since the work of Brun and Englund [8], it has been known that microscopic WM changes are also present in AD.”
BackgroundSong, S.-K., Kim, J. H., Lin, S.-J., Brendza, R. P., & Holtzman, D. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.003 · Cited by 170
Braskie, M. N., Jahanshad, N., Stein, J. L., Barysheva, M., McMahon, K. L., de Zubicaray, G. I., Martin, N. G., Wright, M. J., Ringman, J. M., Toga, A. W., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5794-10.2011 · Cited by 170
Multivariate network analysis of fiber tract integrity in Alzheimer’s disease
Teipel, S. J., Stahl, R., Dietrich, O., Schoenberg, S. O., Perneczky, R., Bokde, A. L. W., Reiser, M. F., Möller, H.-J., & Hampel, H. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.07.047 · Cited by 170
Dementia associated with lacunar infarction.
Loeb, C., Gandolfo, C., Croce, R., & Conti, M. (1992) · Stroke · doi:10.1161/01.str.23.9.1225 · Cited by 169
Phenotypic heterogeneity in familial alzheimer's disease: A study of 24 kindreds
Bird, T. D., Sumi, S. M., Nemens, E. J., Nochlin, D., Schellenberg, G., Lampe, T. H., Sadovnick, A., Chui, H., Miner, G. W., & Tinklenberg, J. (1989) · Annals of Neurology · doi:10.1002/ana.410250104 · Cited by 168
Di Paola, M., Spalletta, G., & Caltagirone, C. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1370 · Cited by 151
The enigma of vascular cognitive disorder and vascular dementia
Jellinger, K. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0185-2 · Cited by 166
Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation
Stirling, D. P., & Stys, P. K. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.02.002 · Cited by 163
Capizzano, A. A. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.019273 · Cited by 163
Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease
Pievani, M., Agosta, F., Pagani, E., Canu, E., Sala, S., Absinta, M., Geroldi, C., Ganzola, R., Frisoni, G. B., & Filippi, M. (2010) · Human Brain Mapping · doi:10.1002/hbm.20978 · Cited by 151
Pathological markers associated with normal aging and dementia in the elderly
Crystal, H. A., Dickson, D. W., Sliwinski, M. J., Lipton, R. B., Grober, E., Marks‐Nelson, H., & Antis, P. (1993) · Annals of Neurology · doi:10.1002/ana.410340410 · Cited by 161
Gootjes, L., Teipel, S. J., Zebuhr, Y., Schwarz, R., Leinsinger, G., Scheltens, P., Möller, H.-J., & Hampel, H. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000079199 · Cited by 161
Altered brain white matter integrity in healthy carriers of the APOE ε4 allele: A risk for AD?
Persson, J., Lind, J., Larsson, A., Ingvar, M., Cruts, M., Van Broeckhoven, C., Adolfsson, R., Nilsson, L. G., & Nyberg, L. (2006) · Neurology · doi:10.1212/01.wnl.0000204180.25361.48 · Cited by 161
Age-Related White Matter Changes
Xiong, Y. Y., & Mok, V. (2011) · Journal of Aging Research · doi:10.4061/2011/617927 · Cited by 141
Grafton, S. T., Sumi, S. M., Stimac, G. K., Alvord, E. C., Shaw, C.-M., & Nochlin, D. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530150061019 · Cited by 155
Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition.
Kobari, M., Meyer, J. S., Ichijo, M., & Oravez, W. T. (1990) · PubMed · Cited by 161
Kalback, W., Esh, C., Castaño, E. M., Rahman, A., Kokjohn, T., Luehrs, D. C., Sue, L., Cisneros, R., Gerber, F., Richardson, C., et al. (2004) · Neurological Research · doi:10.1179/016164104225017668 · Cited by 160
Meyrhoff, D. J., MacKay, S., Constans, J. ‐., Norman, D., Van Dyke, C., Fein, G., & Weiner, M. W. (1994) · Annals of Neurology · doi:10.1002/ana.410360110 · Cited by 160
Postmortem MRI and Histopathology of White Matter Changes in Alzheimer Brains
Bronge, L., Bogdanovic, N., & Wahlund, L.-O. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000057698 · Cited by 159
Leys, D., Pruvo, J. P., Parent, M., Vermersch, P., Soetaert, G., Steinling, M., Delacourte, A., Defossez, A., Rapoport, A., & Clarisse, J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.1.46 · Cited by 159
Hamzé, R., Delangre, E., Tolu, S., Moreau, M., Janel, N., Bailbé, D., & Movassat, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315287 · Cited by 158
Novel White Matter Tract Integrity Metrics Sensitive to Alzheimer Disease Progression
Fieremans, E., Benitez, A., Jensen, J. H., Falangola, M. F., Tabesh, A., Deardorff, R. L., Spampinato, M. V. S., Babb, J. S., Novikov, D. S., Ferris, S. H., et al. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3553 · Cited by 147
Pires, M., & Rego, A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010778 · Cited by 157
“Brain tissues from ApoE4 carriers showed decreased myelin levels [36], concordantly with previous studies demonstrating altered white matter patterns in AD brains [46].”
ResultO’Sullivan, M. (2008) · Practical Neurology · doi:10.1136/jnnp.2007.139428 · Cited by 133
EEG in the differential diagnosis between Alzheimer's disease and vascular dementia
Erkinjuntti, T., Larsen, T., Sulkava, R., Ketonen, L., Laaksonen, R., & Palo, J. (1988) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1988.tb06971.x · Cited by 156
Leys, D., Soetaert, G., Petit, H., Fauquette, A., Pruvo, J.-P., & Steinling, M. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530050040010 · Cited by 147
What causes neurodegenerative disease?
Armstrong, R. (2020) · Folia Neuropathologica · doi:10.5114/fn.2020.96707 · Cited by 126
Diffusion Tensor Imaging and Its Application to Neuropsychiatric Disorders
Kubicki, M., Westin, C.-F., Maier, S. E., Mamata, H., Frumin, M., Ersner-Hershfield, H., Kikinis, R., Jolesz, F. A., McCarley, R., & Shenton, M. E. (2002) · Harvard Review of Psychiatry · doi:10.1080/10673220216231 · Cited by 145
Post-mortem assessment in vascular dementia: advances and aspirations
McAleese, K. E., Alafuzoff, I., Charidimou, A., De Reuck, J., Grinberg, L. T., Hainsworth, A. H., Hortobagyi, T., Ince, P., Jellinger, K., Gao, J., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0676-5 · Cited by 140
Skoog, I., Hesse, C., Aevarsson, O., Landahl, S., Wahlstrom, J., Fredman, P., & Blennow, K. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.1.37 · Cited by 145
Tissue segmentation of the brain in Alzheimer disease.
Tanabe, J., Amend, D. L., Schuff, N. W., Sclafani, V. D., Ezekiel, F., Norman, D. M., Fein, G., & Weiner, M. W. (1997) · PubMed · Cited by 149
Leukoaraiosis: An Independent Risk Factor for Stroke?
Inzitari, D. (2003) · Stroke · doi:10.1161/01.str.0000080934.68280.82 · Cited by 126
Ueno, M., Tomimoto, H., Akiguchi, I., Wakita, H., & Sakamoto, H. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200201000-00012 · Cited by 147
“Although the exact mechanism by which the WM lesions occur is unknown, the trigger may be chronic cerebral ischemia subsequent to fibrohyalinosis of the long, penetrating arteries in the deep WM (Brun and Englund, 1986; Lin et al., 2000).”
BackgroundFluency and memory differences between ischemic vascular dementia and Alzheimer's disease.
Lafosse, J. M., Reed, B. R., Mungas, D., Sterling, S. B., Wahbeh, H., & Jagust, W. J. (1997) · Neuropsychology · doi:10.1037//0894-4105.11.4.514 · Cited by 123
MR signal abnormalities in memory disorder and dementia.
Bowen, B. C., Barker, W., Loewenstein, D., Sheldon, J. J., & Duara, R. (1990) · American Journal of Roentgenology · doi:10.2214/ajr.154.6.2110743 · Cited by 147
Overlap between neurodegenerative disorders
Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00605.x · Cited by 146
“Third, more complex forms of AD have been described, for example, AD overlapping with PkD,(85) or associated with significant degeneration of white matter.(86) Fourth, there may be forms of AD with severe capillary amyloid angiopathy(87) or with the development of LB,(88) and thus overlapping with DLB.”
BackgroundZhuang, L., Sachdev, P. S., Trollor, J. N., Reppermund, S., Kochan, N. A., Brodaty, H., & Wen, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058887 · Cited by 136
Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice
Bellucci, A., Luccarini, I., Scali, C., Prosperi, C., Giovannini, M. G., Pepeu, G., & Casamenti, F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.03.012 · Cited by 130
Cognition and White Matter Changes on Magnetic Resonance Imaging in Dementia
Kertesz, A., Polk, M. J., & Carr, T. J. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530040029015 · Cited by 144
ENGLUND, E., & BRUN, A. (1990) · Histopathology · doi:10.1111/j.1365-2559.1990.tb01542.x · Cited by 138
Self-citationVoineskos, A. N., Lerch, J. P., Felsky, D., Shaikh, S., Rajji, T. K., Miranda, D., Lobaugh, N. J., Mulsant, B. H., Pollock, B. G., & Kennedy, J. L. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.194 · Cited by 126
Alterations in Glia and Axons in the Brains of Binswanger’s Disease Patients
Akiguchi, I., Tomimoto, H., Suenaga, T., Wakita, H., & Budka, H. (1997) · Stroke · doi:10.1161/01.str.28.7.1423 · Cited by 130
Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease
Wallin, A., Román, G. C., Esiri, M. M., Kettunen, P., Svensson, J., Paraskevas, G. P., & Kapaki, E. N. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170803 · Cited by 141
Phosphodiesterases in neurodegenerative disorders
Bollen, E., & Prickaerts, J. (2012) · IUBMB Life · doi:10.1002/iub.1104 · Cited by 141
Neuropathologic Correlates of Leuko-araiosis
Janota, I., Mirsen, T. R., Hachinski, V. C., Lee, D. H., & Merskey, H. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460118023 · Cited by 138
White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution
Garnier‐Crussard, A., Cotton, F., Krolak‐Salmon, P., & Chételat, G. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13057 · Cited by 139
Primary Cerebral Blood Flow Deficiency and Alzheimer's Disease: Shadows and Lights
Mazza, M., Marano, G., Traversi, G., Bria, P., & Mazza, S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-090700 · Cited by 129
Significant association between leukoaraiosis and metabolic syndrome in healthy subjects
Park, K., Yasuda, N., Toyonaga, S., Yamada, S. M., Nakabayashi, H., Nakasato, M., Nakagomi, T., Tsubosaki, E., & Shimizu, K. (2007) · Neurology · doi:10.1212/01.wnl.0000266562.54684.bf · Cited by 138
White Matter Changes in Stroke Patients
Leys, D., Englund, E., Del Ser, T., Inzitari, D., Fazekas, F., Bornstein, N., Erkinjuntti, T., Bowler, J. V., Pantoni, L., Parnetti, L., et al. (1999) · European Neurology · doi:10.1159/000069414 · Cited by 122
Self-citationPathology of Alzheimer's Disease
Blass, J. P., Ko, B., & Wisniewski, H. M. (1991) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30315-0 · Cited by 138
Is Alzheimer’s a disease of the white matter?
Sachdev, P. S., Zhuang, L., Braidy, N., & Wen, W. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835ed6e8 · Cited by 137
“Nonetheless, the majority of this white matter damage has been attributed to small cerebrovascular disease that cooccurred with Alzheimer’s disease related neuropathology [36,37].”
BackgroundMapping mean axon diameter and axonal volume fraction by MRI using temporal diffusion spectroscopy
Xu, J., Li, H., Harkins, K. D., Jiang, X., Xie, J., Kang, H., Does, M. D., & Gore, J. C. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.09.006 · Cited by 130
Older people with impaired mobility have specific loci of periventricular abnormality on MRI
Benson, R. R., Guttmann, C. R. G., Wei, X., Warfield, S. K., Hall, C., Schmidt, J. A., Kikinis, R., & Wolfson, L. I. (2002) · Neurology · doi:10.1212/wnl.58.1.48 · Cited by 129
Pérez-Torres, S., Cortés, R., Tolnay, M., Probst, A., Palacios, J. M., & Mengod, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00042-6 · Cited by 137
Duan, J., Wang, H., Xu, J., Lin, X. Z., Chen, S., Kang, Z., & Yao, Z. (2006) · Surgical and Radiologic Anatomy · doi:10.1007/s00276-006-0111-2 · Cited by 137
Vascular Dementia: A Contemporary Review of Epidemiology, Diagnosis, Prevention, and Treatment
Nyenhuis, D. L., & Gorelick, P. B. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb06015.x · Cited by 115
Vascular dementia: still a debatable entity?
Loeb, C., & Meyer, J. S. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00191-8 · Cited by 135
DTI analyses and clinical applications in Alzheimer’s disease
Oishi, K., Mielke, M. M., Albert, M., Lyketsos, C. G., & Mori, S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-0007 · Cited by 134
“Consistently, pathological studies have revealed various types of white matter alterations in AD, such as altered myelin and oligodendrocytes, axonal degeneration, and vascular pathologies [37–39].”
Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions
Van Dijk, E. J., Prins, N. D., Vermeer, S. E., Hofman, A., Van Duijn, C. M., Koudstaal, P. J., & Breteler, M. M. B. (2004) · Annals of Neurology · doi:10.1002/ana.20050 · Cited by 120
Kovacs, G. G., Robinson, J. L., Xie, S. X., Lee, E. B., Grossman, M., Wolk, D. A., Irwin, D. J., Weintraub, D., Kim, C. F., Schuck, T., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx007 · Cited by 132
Du, A., Schuff, N. W., Chao, L. L., Kornak, J., Ezekiel, F., Jagust, W. J., Kramer, J. H., Reed, B., Miller, B. L., Norman, D. M., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.05.002 · Cited by 130
Erkinjuntti, T., Gao, F., Lee, D. H., Eliasziw, M., Merskey, H., & Hachinski, V. C. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540150054016 · Cited by 122
Leukoaraiosis and vascular dementia
van Gijn, J. (1998) · Neurology · doi:10.1212/wnl.51.3_suppl_3.s3 · Cited by 117
The relationship between blood pressure and dementia: a review
Skoog, I. G. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)89428-0 · Cited by 129
Tell, G. S., Lefkowitz, D. S., Diehr, P., & Elster, A. D. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.73 · Cited by 125
KENT, D. L., & Larson, E. B. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-402 · Cited by 128
Gannon, O. J., Robison, L. S., Salinero, A. E., Abi-Ghanem, C., Mansour, F. M., Kelly, R. D., Tyagi, A., Brawley, R. R., Ogg, J. D., & Zuloaga, K. L. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02466-2 · Cited by 127
Kozachuk, W. E. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120050009 · Cited by 119
Hénon, H., Pasquier, F., & Leys, D. (2006) · Cerebrovascular Diseases · doi:10.1159/000092923 · Cited by 125
Occurrence of subcortical hyperintensities in elderly subjects with mania
McDonald, W. M., Krishnan, K., Doraiswamy, P. M., & Blazer, D. G. (1991) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(91)90013-g · Cited by 125
Metadata
- Authors
- Brun, A., & Englund, E.
- Affiliations
- Skåne University Hospital (SE)
- Corresponding author
- Brun, A.
- ORCID
- Englund, E.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1986-03
- Volume
- 19
- Issue
- 3
- Pages
- 253-262
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2017159332
- Cited by
- 1,014
- References
- 34
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 15 · 2023: 25 · 2022: 19 · 2021: 14 · 2020: 18 · 2019: 21 · 2018: 24 · 2017: 22 · 2016: 22 · 2015: 23 · 2014: 37 · 2013: 33 · 2012: 30
- FWCI
- 26.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- Alzheimer's disease, senile dementia of the Alzheimer type, white matter disease, deep white matter, demyelination, oligodendrocyte loss, astrocytic gliosis, cerebral hypoperfusion, cardiovascular disease, Binswanger disease, cerebrovascular disease, Wallerian degeneration
- MeSH terms
- Aged, Alzheimer Disease, Brain, Cardiovascular Diseases, Cerebral Infarction, Dementia, Humans, Middle Aged, Periaqueductal Gray, Severity of Illness Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.